A Transcriptional Signature of IL-2 Expanded Natural Killer Cells Predicts More Favorable Prognosis in Bladder Cancer
Activation of natural killer (NK) cell function is regulated by cytokines, such as IL-2, and secreted factors upregulated in the tumor microenvironment, such as platelet-derived growth factor D (PDGF-DD). In order to elucidate a clinical role for these important regulators of NK cell function in ant...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9a25b716f78e484a8ead390e5f420cf3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:9a25b716f78e484a8ead390e5f420cf3 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:9a25b716f78e484a8ead390e5f420cf32021-11-10T07:28:17ZA Transcriptional Signature of IL-2 Expanded Natural Killer Cells Predicts More Favorable Prognosis in Bladder Cancer1664-322410.3389/fimmu.2021.724107https://doaj.org/article/9a25b716f78e484a8ead390e5f420cf32021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.724107/fullhttps://doaj.org/toc/1664-3224Activation of natural killer (NK) cell function is regulated by cytokines, such as IL-2, and secreted factors upregulated in the tumor microenvironment, such as platelet-derived growth factor D (PDGF-DD). In order to elucidate a clinical role for these important regulators of NK cell function in antitumor immunity, we generated transcriptional signatures representing resting, IL-2-expanded, and PDGF-DD-activated, NK cell phenotypes and established their abundance in The Cancer Genome Atlas bladder cancer (BLCA) dataset using CIBERSORT. The IL-2-expanded NK cell phenotype was the most abundant in low and high grades of BLCA tumors and was associated with improved prognosis. In contrast, PDGFD expression was associated with numerous cancer hallmark pathways in BLCA tumors compared with normal bladder tissue, and a high tumor abundance of PDGFD transcripts and the PDGF-DD-activated NK cell phenotype were associated with a poor BLCA prognosis. Finally, high tumor expression of transcripts encoding the activating NK cell receptors, KLRK1 and the CD160–TNFRSF14 receptor–ligand pair, was strongly correlated with the IL-2-expanded NK cell phenotype and improved BLCA prognosis. The transcriptional parameters we describe may be optimized to improve BLCA patient prognosis and risk stratification in the clinic and potentially provide gene targets of therapeutic significance for enhancing NK cell antitumor immunity in BLCA.Yuhan SunAlexander James SedgwickMd Abdullah-Al-Kamran KhanYaseelan PalarasahStefano MangiolaAlexander David BarrowFrontiers Media S.A.articleNK cellbladder cancerprognosisNK receptorsTCGAanti-tumor immunityImmunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
NK cell bladder cancer prognosis NK receptors TCGA anti-tumor immunity Immunologic diseases. Allergy RC581-607 |
spellingShingle |
NK cell bladder cancer prognosis NK receptors TCGA anti-tumor immunity Immunologic diseases. Allergy RC581-607 Yuhan Sun Alexander James Sedgwick Md Abdullah-Al-Kamran Khan Yaseelan Palarasah Stefano Mangiola Alexander David Barrow A Transcriptional Signature of IL-2 Expanded Natural Killer Cells Predicts More Favorable Prognosis in Bladder Cancer |
description |
Activation of natural killer (NK) cell function is regulated by cytokines, such as IL-2, and secreted factors upregulated in the tumor microenvironment, such as platelet-derived growth factor D (PDGF-DD). In order to elucidate a clinical role for these important regulators of NK cell function in antitumor immunity, we generated transcriptional signatures representing resting, IL-2-expanded, and PDGF-DD-activated, NK cell phenotypes and established their abundance in The Cancer Genome Atlas bladder cancer (BLCA) dataset using CIBERSORT. The IL-2-expanded NK cell phenotype was the most abundant in low and high grades of BLCA tumors and was associated with improved prognosis. In contrast, PDGFD expression was associated with numerous cancer hallmark pathways in BLCA tumors compared with normal bladder tissue, and a high tumor abundance of PDGFD transcripts and the PDGF-DD-activated NK cell phenotype were associated with a poor BLCA prognosis. Finally, high tumor expression of transcripts encoding the activating NK cell receptors, KLRK1 and the CD160–TNFRSF14 receptor–ligand pair, was strongly correlated with the IL-2-expanded NK cell phenotype and improved BLCA prognosis. The transcriptional parameters we describe may be optimized to improve BLCA patient prognosis and risk stratification in the clinic and potentially provide gene targets of therapeutic significance for enhancing NK cell antitumor immunity in BLCA. |
format |
article |
author |
Yuhan Sun Alexander James Sedgwick Md Abdullah-Al-Kamran Khan Yaseelan Palarasah Stefano Mangiola Alexander David Barrow |
author_facet |
Yuhan Sun Alexander James Sedgwick Md Abdullah-Al-Kamran Khan Yaseelan Palarasah Stefano Mangiola Alexander David Barrow |
author_sort |
Yuhan Sun |
title |
A Transcriptional Signature of IL-2 Expanded Natural Killer Cells Predicts More Favorable Prognosis in Bladder Cancer |
title_short |
A Transcriptional Signature of IL-2 Expanded Natural Killer Cells Predicts More Favorable Prognosis in Bladder Cancer |
title_full |
A Transcriptional Signature of IL-2 Expanded Natural Killer Cells Predicts More Favorable Prognosis in Bladder Cancer |
title_fullStr |
A Transcriptional Signature of IL-2 Expanded Natural Killer Cells Predicts More Favorable Prognosis in Bladder Cancer |
title_full_unstemmed |
A Transcriptional Signature of IL-2 Expanded Natural Killer Cells Predicts More Favorable Prognosis in Bladder Cancer |
title_sort |
transcriptional signature of il-2 expanded natural killer cells predicts more favorable prognosis in bladder cancer |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/9a25b716f78e484a8ead390e5f420cf3 |
work_keys_str_mv |
AT yuhansun atranscriptionalsignatureofil2expandednaturalkillercellspredictsmorefavorableprognosisinbladdercancer AT alexanderjamessedgwick atranscriptionalsignatureofil2expandednaturalkillercellspredictsmorefavorableprognosisinbladdercancer AT mdabdullahalkamrankhan atranscriptionalsignatureofil2expandednaturalkillercellspredictsmorefavorableprognosisinbladdercancer AT yaseelanpalarasah atranscriptionalsignatureofil2expandednaturalkillercellspredictsmorefavorableprognosisinbladdercancer AT stefanomangiola atranscriptionalsignatureofil2expandednaturalkillercellspredictsmorefavorableprognosisinbladdercancer AT alexanderdavidbarrow atranscriptionalsignatureofil2expandednaturalkillercellspredictsmorefavorableprognosisinbladdercancer AT yuhansun transcriptionalsignatureofil2expandednaturalkillercellspredictsmorefavorableprognosisinbladdercancer AT alexanderjamessedgwick transcriptionalsignatureofil2expandednaturalkillercellspredictsmorefavorableprognosisinbladdercancer AT mdabdullahalkamrankhan transcriptionalsignatureofil2expandednaturalkillercellspredictsmorefavorableprognosisinbladdercancer AT yaseelanpalarasah transcriptionalsignatureofil2expandednaturalkillercellspredictsmorefavorableprognosisinbladdercancer AT stefanomangiola transcriptionalsignatureofil2expandednaturalkillercellspredictsmorefavorableprognosisinbladdercancer AT alexanderdavidbarrow transcriptionalsignatureofil2expandednaturalkillercellspredictsmorefavorableprognosisinbladdercancer |
_version_ |
1718440492789661696 |